Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
11,847.5551.1
Stock Analysis, IPO, Mutual Funds, Bonds & More
NCLT approves Dhanuka Lab’s Rs 1,116 crore plan to buy debt-hit Orchid Pharma

A consortium of 24 banks has lent a total of over Rs 3,200 crore to the drug maker and the lenders will be taking a haircut of around 65%.

Novartis wins Gilenya reprieve as judge blocks generics, for now

The judge said letting generics makers sell their versions before the patent dispute was decided would damage the Swiss drugmaker more than those wanting a piece of Gilenya's market.

Optimising product portfolio, focusing on key brands: GSK Pharmaceuticals

"The business has embarked on it new strategy this year, as we put in place an optimal commercial structure and worked at building capability," GSK Pharmaceuticals MD (India) A Vaidheesh told PTI.

Glenmark Pharma says USFDA has issued CRL for Ryaltris

The CRL cites deficiencies in the Drug Master File pertaining to one of the active pharmaceutical ingredients and in manufacturing facilities, the company said in a regulatory filing.

Price of 1032 medicines capped by govt: Mansukhlal Mandavia

He said Jan Aushadhi stores are opened with an aim of providing quality and affordable medicines to the poor.

Aurobindo Pharma gets warning letter from USFDA for Andhra Pradesh unit

The drug firm, however, did not provide any details of the contents of the warning letter received from the regulator.

Advent International emerges sole bidder for Bharat Serums

Kotak PE and OrbiMed together hold 23% stake in BSV. The rest of the stake is with the Daftary family.

Indian Pharma industry aspiring to grow to $120-130 billion by 2030: IPA

The report is based on a research collaboration with McKinsey & Co and inputs from the IPA members and industry leaders, IPA said in a statement.

Fourth carcinogen discovered in heart pills used by millions

DMF, as the solvent is known, is classified by the World Health Organization as a probable carcinogen.

USFDA for voluntary action by Cadila Healthcare on Ahmedabad SEZ facility

The plant has received an establishment inspection report (EIR). The EIR report stated that the classification of the facility is VAI, it added.

New psoriasis drug study yields positive results: Dr Reddy's

New psoriasis drug study yields positive results: Dr Reddy's

According to a press release from the city-based drug-maker, the detailed safety and efficacy data from the study would be presented in future dermatology conferences.

World needs generic drugs but their quality must be guaranteed: Journalist Katherine Eban

World needs generic drugs but their quality must be guaranteed: Journalist Katherine Eban

Eban discusses her findings and how regulators and countries need to step up to protect patients.

Aurobindo Pharma says co, subsidiary made party to litigation proceeding in US

Aurobindo Pharma says co, subsidiary made party to litigation proceeding in US

The drug firm in a regulatory filing however said it is yet to receive a copy of the proceeding and denied what it said were 'baseless allegations' against the company.

USFDA issues 9 observations to Natco Pharma's Kothur facility

USFDA issues 9 observations to Natco Pharma's Kothur facility

"At the end of the inspection, the facility received 9 observations, with no repeat observations and mostly procedural in nature," Natco Pharma said in a BSE filing.

AstraZeneca's blood cancer drug meets main goal in late-stage trial

AstraZeneca's blood cancer drug meets main goal in late-stage trial

The drug, Calquence, showed meaningful improvement in patients with lymphocytic leukaemia when compared with a chemotherapy-based treatment, the company said.

Alembic Pharma gets USFDA nod for Parkinson's disease treatment drugs

Alembic Pharma gets USFDA nod for Parkinson's disease treatment drugs

Quoting IQVIA sales data, the company said the two products had an estimated market size of USD 24 million for 12 months ended December 2018.

PHARMACEUTICALS STOCKS
NSE
BSE

Company NameLatestChange%ChangeVolume
Nifty Pharma8086.3139.11.750
Sun Pharmaceutical Industries399.4513.73.559571797
Earnest Healthcare Ltd.0000
Yogi Healthcare Ltd.0000
Cipla556.556.51.181020879
Divis Laboratories1597.95-4.45-0.28461263
Load More...
1

Other useful Links


Follow us on


Download et app


Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

BACK TO TOP